"When I can get potential blue-sky regenerative technologies like RP's at this small valuation, I'm buying." (8/12/15) RepliCel Life Sciences Inc. - The Life Sciences Report Interview with Eden Rahim More >
Subscribe to Streetwise Reports’ Newsletters
Receive weekly insight into today’s investment ideas from leading analysts and experts.
To make sure our emails arrive in your inbox, please add email@example.com to your "safe sender" list. If you are unsure how to whitelist or add someone to your safe senders list, please follow the instructions here.
"RGS is actively seeking Japanese partners for its adipose-derived mesenchymal stem cell osteoarthritis drug, Progenza." (8/5/15) Regeneus Ltd. - The Life Sciences Report Interview with Colin Lee Novick More >